The global Peptide and Anticoagulant Drugs Market is on a significant upward trajectory, with its market value estimated at USD 92.63 billion in 2023 and projected to grow to USD 173.99 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.24% over the forecast period from 2024 to 2032. Driven by the increasing prevalence of chronic conditions, advancements in drug development...